AGP Picks
View all

Tennessee Healthcare Today
Provided by AGP

Tennessee Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Healthcare Today.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 19, 2026

Brain Cancer Canada Invests $75,000 in Groundbreaking Glioblastoma Research at University of Alberta, Targeting How Tumours “Communicate”
May 19, 2026

Brain Cancer Canada Invests $75,000 in Groundbreaking Glioblastoma Research at University of Alberta, Targeting How Tumours “Communicate”

Indeterminate GlobeNewswire
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
May 19, 2026

Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology

Indeterminate GlobeNewswire
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
May 19, 2026

Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease

Indeterminate GlobeNewswire
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
May 19, 2026

Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

Indeterminate GlobeNewswire
CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks
May 19, 2026

CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks

Indeterminate GlobeNewswire
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
May 19, 2026

Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress

Indeterminate GlobeNewswire
Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences
May 19, 2026

Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences

Indeterminate GlobeNewswire
Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease
May 19, 2026

Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease

Indeterminate GlobeNewswire
Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
May 19, 2026

Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Indeterminate GlobeNewswire
EyePoint Announces Participation at Upcoming Investor Conferences
May 19, 2026

EyePoint Announces Participation at Upcoming Investor Conferences

Indeterminate GlobeNewswire
XORTX Announces Closing of US$5 Million Public Offering
May 19, 2026

XORTX Announces Closing of US$5 Million Public Offering

Indeterminate GlobeNewswire
Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 19, 2026

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Indeterminate GlobeNewswire
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 19, 2026

Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Indeterminate GlobeNewswire
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
May 19, 2026

Medicenna Announces the Finalization of the Terms of its Public Offering of Securities

Indeterminate GlobeNewswire
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 19, 2026

OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD

Indeterminate GlobeNewswire
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
May 19, 2026

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Indeterminate GlobeNewswire
Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
May 19, 2026

Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand

Indeterminate GlobeNewswire
EuroPCR 2026: DynamX® Bioadaptor von Elixir Medical zeigt in der Langzeit-Nachbeobachtung signifikant niedrigere Ereignisraten als ein medikamentenfreisetzender Stent
May 19, 2026

EuroPCR 2026: DynamX® Bioadaptor von Elixir Medical zeigt in der Langzeit-Nachbeobachtung signifikant niedrigere Ereignisraten als ein medikamentenfreisetzender Stent

Indeterminate GlobeNewswire
EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent
May 19, 2026

EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent

Indeterminate GlobeNewswire
El bioadaptador DynamX® de Elixir Medical demuestra tasas de acontecimientos significativamente inferiores a las de los stents liberadores de fármacos
May 19, 2026

El bioadaptador DynamX® de Elixir Medical demuestra tasas de acontecimientos significativamente inferiores a las de los stents liberadores de fármacos

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tennessee Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.